Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, LT01102, Vilnius, Lithuania.
J Cell Biochem. 2013 Sep;114(9):2024-31. doi: 10.1002/jcb.24550.
The involvement of extracellular signal-regulated kinases 1 and 2 (ERK1,2), stress kinase p38 and c-Jun NH2 -terminal kinases 1 and 2 (JNK1,2) on Hsp70-upregulation following mild heat shock, and resulting cell protection, was studied on rabbit primary myoblasts. Cells subjected to heat stress (42°C; 60 min) showed a significantly enhanced amount of heat-shock-induced protein 70 (Hsp70), correlating with sustained phosphorylation of MAP kinases ERK1,2, inhibition of p38 and JNK1,2 activation. Induced Hsp70 did not autocrinally suppress activation of transcription factor c-Jun, suggesting involvement of the latter in the protection of myoblasts following heat shock. The inhibition of stress kinases p38, JNK1,2, and MEK1,2 by SP600125, SB203580, and UO126, respectively, established the involvement of JNK1,2 and p38 as upstream, and ERK1,2 as downstream targets of Hsp70 induction. Moreover, the effect of the MEK1,2 inhibitor UO126 revealed a new pathway of c-Jun activation by ERK1,2 in myogenic heat-stressed stem cells. The presented data show that transient activation of JNK1, JNK2, and p38 is necessary for Hsp70 induction and ensuing cell protection. In conclusion, affecting myogenic stem cell protective mechanisms might be a useful strategy in improving stem cell survival and their expanded application in therapy.
研究了细胞外信号调节激酶 1 和 2(ERK1,2)、应激激酶 p38 和 c-Jun NH2-末端激酶 1 和 2(JNK1,2)在轻度热休克后热休克诱导蛋白 70(Hsp70)上调以及由此产生的细胞保护中的作用,这是在兔原代成肌细胞上进行的。经受热应激(42°C;60 分钟)的细胞显示出明显增强的热休克诱导蛋白 70(Hsp70)量,与 MAP 激酶 ERK1,2 的持续磷酸化、p38 和 JNK1,2 激活的抑制相关。诱导的 Hsp70 不会自动抑制转录因子 c-Jun 的激活,这表明 c-Jun 参与了热休克后成肌细胞的保护。应激激酶 p38、JNK1,2 和 MEK1,2 的抑制剂 SP600125、SB203580 和 UO126 分别抑制了 JNK1,2 和 p38,以及 ERK1,2 的激活,确定了 JNK1,2 和 p38 作为 Hsp70 诱导的上游,而 ERK1,2 作为下游靶标。此外,MEK1,2 抑制剂 UO126 的作用揭示了 ERK1,2 在肌源性热应激干细胞中 c-Jun 激活的新途径。所呈现的数据表明,JNK1、JNK2 和 p38 的短暂激活对于 Hsp70 的诱导和随后的细胞保护是必要的。总之,影响成肌干细胞的保护机制可能是提高干细胞存活及其在治疗中广泛应用的有用策略。